Literature DB >> 25798268

Patient age, tumor appearance and tumor size are risk factors for early recurrence of cervical cancer.

Juan Wang1, Tao Wang1, Yun-Yi Yang1, Yan-Lan Chai1, Fan Shi1, Z I Liu1.   

Abstract

The recurrence and metastasis of cervical cancer contribute to a poor prognosis. The aim of this study was to investigate the risk factors for cervical cancer progression. A total of 284 patients with recurrent cervical cancer were retrospectively recruited to evaluate the association of disease recurrence with clinicopathological data. The univariate analysis demonstrated that patient age, tumor appearance and tumor size were significantly associated with early recurrence and metastasis of the disease (P<0.05). However, clinical stage, tumor histology, pathological stage and initial treatment options were not associated with early recurrence and metastasis of cervical cancer (P>0.05). The multivariate analysis also demonstrated that patient age, tumor appearance and tumor size were independent risk factors for the early recurrence of cervical cancer (P<0.05). Therefore, these three factors should be taken into consideration in the management of cervical cancer.

Entities:  

Keywords:  cervical cancer; concurrent chemoradiotherapy; radical surgery; recurrence

Year:  2014        PMID: 25798268      PMCID: PMC4360871          DOI: 10.3892/mco.2014.465

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  21 in total

1.  Carcinoma of the cervix uteri.

Authors:  J L Benedet; F Odicino; P Maisonneuve; U Beller; W T Creasman; A P Heintz; H Y Ngan; S Pecorelli
Journal:  Int J Gynaecol Obstet       Date:  2003-10       Impact factor: 3.561

Review 2.  Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.

Authors:  Edward P Armstrong
Journal:  J Manag Care Pharm       Date:  2010-04

Review 3.  The role of surgery after chemoradiation therapy and brachytherapy for stage IB2/II cervical cancer.

Authors:  P Morice; C Uzan; Y Zafrani; Y Delpech; S Gouy; C Haie-Meder
Journal:  Gynecol Oncol       Date:  2007-08-29       Impact factor: 5.482

4.  Radical pelvic surgery versus radiation therapy for stage I carcinoma of the cervix (exclusive of microinvasion).

Authors:  G W Morley; J C Seski
Journal:  Am J Obstet Gynecol       Date:  1976-12-01       Impact factor: 8.661

5.  Close vaginal margins as a prognostic factor after radical hysterectomy.

Authors:  R E Estape; R Angioli; M Madrigal; M Janicek; C Gomez; M Penalver; H Averette
Journal:  Gynecol Oncol       Date:  1998-03       Impact factor: 5.482

6.  Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer).

Authors:  J M Classe; P Rauch; J F Rodier; P Morice; E Stoeckle; S Lasry; G Houvenaeghel
Journal:  Gynecol Oncol       Date:  2006-02-28       Impact factor: 5.482

7.  Cervical cancer in young women in Taiwan: prognosis is independent of papillomavirus or tumor cell type.

Authors:  Y C Yang; J Shen; J E Tate; K G Wang; T H Su; K L Wang; C J Jeng; H S Chen; S Chiang; C P Crum
Journal:  Gynecol Oncol       Date:  1997-01       Impact factor: 5.482

8.  A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer.

Authors:  A Goncalves; M Fabbro; C Lhommé; L Gladieff; J-M Extra; A Floquet; L Chaigneau; A Tisseron Carrasco; P Viens
Journal:  Gynecol Oncol       Date:  2007-11-05       Impact factor: 5.482

Review 9.  Management of recurrent cervical cancer. Review of the literature and case report.

Authors:  Ph Elst; F Ahankour; W Tjalma
Journal:  Eur J Gynaecol Oncol       Date:  2007       Impact factor: 0.196

10.  Concurrent 5-fluorouracil, mitomycin C and radiation with or without brachytherapy in recurrent cervical cancer: a scoring system to predict clinical response and outcome.

Authors:  Daniela Smaniotto; Giuseppe D'Agostino; Stefano Luzi; Vincenzo Valentini; Gabriella Macchia; Giovanna Mantini; Pasquale Alessandro Margariti; Gabriella Ferrandina; Giovanni Scambia
Journal:  Tumori       Date:  2005 Jul-Aug
View more
  12 in total

1.  MiR-106b-5p Promotes Malignant Behaviors of Cervical Squamous Cell Carcinoma Cells by Targeting TIMP2.

Authors:  Huier Sun; Xuejun Chen
Journal:  Reprod Sci       Date:  2021-11-12       Impact factor: 3.060

2.  Prognostic Significance of Clinicopathological Factors Influencing Overall Survival and Event-Free Survival of Patients with Cervical Cancer: A Systematic Review and Meta-Analysis.

Authors:  Shengwei Kang; Junxiang Wu; Jie Li; Qing Hou; Bin Tang
Journal:  Med Sci Monit       Date:  2022-03-09

3.  Young Cervical Cancer Patients May Be More Responsive than Older Patients to Neoadjuvant Chemotherapy Followed by Radical Surgery.

Authors:  Jin Zhou; Xiong Li; Kecheng Huang; Yao Jia; Fangxu Tang; Haiying Sun; Yuan Zhang; Qinghua Zhang; Ding Ma; Shuang Li
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

4.  Prognosis-Predicting Model Based on [18F]fluorodeoxyglucose PET Metabolic Parameters in Locally Advanced Cervical Cancer Patients Treated with Concurrent Chemoradiotherapy: Multi-Center Retrospective Study.

Authors:  Won Kee Lee; Gun Oh Chong; Shin Young Jeong; Hyun Jung Lee; Shin-Hyung Park; Jung Min Ryu; Youn Seok Choi; Sungmin Kang; Yu-Jin Koo; Dae Hyung Lee; Eunjung Kong; Sang-Woo Lee
Journal:  J Clin Med       Date:  2020-02-05       Impact factor: 4.241

5.  Nomogram Predicting Overall Survival in Patients with FIGO II to III Squamous Cell Cervical Carcinoma Under Radical Radiotherapy: A Retrospective Analysis Based on 2018 FIGO Staging.

Authors:  Lele Zang; Qin Chen; Xiaozhen Zhang; Xiaohong Zhong; Jian Chen; Yi Fang; An Lin; Min Wang
Journal:  Cancer Manag Res       Date:  2021-12-29       Impact factor: 3.989

6.  Outcome and prognostic factors in cervical cancer patients treated with surgery and concurrent chemoradiotherapy: a retrospective study.

Authors:  Yan-Mei Liu; Ling-Qin Ni; Sai-Sai Wang; Qian-Ling Lv; Wei-Jun Chen; Shen-Peng Ying
Journal:  World J Surg Oncol       Date:  2018-01-29       Impact factor: 2.754

7.  Chemoradiotherapy in combination with radical surgery is associated with better outcome in cervical cancer patients.

Authors:  Dan Zheng; Hua-Ping Mou; Peng Diao; Xiao-Ming Li; Chuan-Li Zhang; Jing Jiang; Jia-Lian Chen; Li-Shuai Wang; Qiu Wang; Guang-Yuan Zhou; Jie Chen; Chuan Lin; Zhi-Ping Yuan
Journal:  Oncotarget       Date:  2017-12-08

8.  Kindlin‑2 suppresses cervical cancer cell migration through AKT/mTOR‑mediated autophagy induction.

Authors:  Guangteng Wu; Ying Long; Yan Lu; Yiming Feng; Xinmei Yang; Xun Xu; Desheng Yao
Journal:  Oncol Rep       Date:  2020-05-04       Impact factor: 3.906

9.  Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1.

Authors:  Chen-Fei Zhou; Jing Ma; Lei Huang; Hong-Yan Yi; Yan-Mei Zhang; Xiang-Guang Wu; Rui-Ming Yan; Li Liang; Mei Zhong; Yan-Hong Yu; Sha Wu; Wei Wang
Journal:  Oncogene       Date:  2018-09-25       Impact factor: 8.756

10.  Prognosis of stage III cervical cancer: a two-way outcome study.

Authors:  Huihui Zhou; Qi Li; Chunyan Xu; Hong Liang; Yanan Wang; Yani Duan; Min Song; Yaoxian Wang; Hong Jin; Tong Wang
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.